Works by PERKOVIC, VLADO
Results: 177
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2015, v. 2, n. 1, p. 1, doi. 10.1186/s40697-015-0066-5
- By:
- Publication type:
- Article
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
- Published in:
- Canadian Journal of Kidney Health & Disease, 2015, v. 2, p. 1, doi. 10.1186/s40697-015-0066-5
- By:
- Publication type:
- Article
No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial.
- Published in:
- Nephrology, 2020, v. 25, n. 10, p. 792, doi. 10.1111/nep.13737
- By:
- Publication type:
- Article
Quality of life in caregivers compared with dialysis recipients: The Co‐ACTIVE sub‐study of the ACTIVE dialysis trial.
- Published in:
- Nephrology, 2019, v. 24, n. 10, p. 1056, doi. 10.1111/nep.13530
- By:
- Publication type:
- Article
Effect of extended hours dialysis on sleep quality in a randomized trial.
- Published in:
- Nephrology, 2019, v. 24, n. 4, p. 430, doi. 10.1111/nep.13236
- By:
- Publication type:
- Article
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
- Published in:
- Nephrology, 2017, v. 22, n. 7, p. 548, doi. 10.1111/nep.12815
- By:
- Publication type:
- Article
Chronic kidney disease in Asia: Protocol for a collaborative overview.
- Published in:
- Nephrology, 2017, v. 22, n. 6, p. 456, doi. 10.1111/nep.12821
- By:
- Publication type:
- Article
Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': The ACTIVE Dialysis Study.
- Published in:
- Nephrology, 2015, v. 20, n. 4, p. 257, doi. 10.1111/nep.12385
- By:
- Publication type:
- Article
The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events ( BLOCADE) Feasibility Study.
- Published in:
- Nephrology, 2015, v. 20, n. 3, p. 140, doi. 10.1111/nep.12362
- By:
- Publication type:
- Article
Cardiovascular disease in patients with chronic kidney disease.
- Published in:
- Nephrology, 2014, v. 19, n. 1, p. 3, doi. 10.1111/nep.12148
- By:
- Publication type:
- Article
Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk.
- Published in:
- Nephrology, 2012, v. 17, n. 5, p. 433, doi. 10.1111/j.1440-1797.2012.01618.x
- By:
- Publication type:
- Article
A challenge to chronic kidney disease in Asia: The report of the second Asian Forum of Chronic Kidney Disease Initiative.
- Published in:
- Nephrology, 2010, v. 15, n. 2, p. 248, doi. 10.1111/j.1440-1797.2009.01269.x
- By:
- Publication type:
- Article
How to read a report of a randomized controlled trial.
- Published in:
- Nephrology, 2010, v. 15, n. 2, p. 153, doi. 10.1111/j.1440-1797.2009.01275.x
- By:
- Publication type:
- Article
Diuretics: A modern day treatment option? (Review Article).
- Published in:
- Nephrology, 2006, v. 11, n. 5, p. 419, doi. 10.1111/j.1440-1797.2006.00598.x
- By:
- Publication type:
- Article
Dose of haemodialysis.
- Published in:
- 2005
- By:
- Publication type:
- Other
ACCELERATED PROGRESSION OF CALCIFIC AORTIC STENOSIS IN DIALYSIS PATIENTS.
- Published in:
- 2002
- By:
- Publication type:
- Abstract
PARATHYROID HORMONE HAS A PROSCLEROTIC EFFECT ON VASCULAR SMOOTH MUSCLE CELLS.
- Published in:
- 2002
- By:
- Publication type:
- Abstract
LONG TERM OUTCOMES OF STENT INSERTION FOR RENAL ARTERY STENOSIS.
- Published in:
- 2002
- By:
- Publication type:
- Abstract
Socioeconomic Disadvantage and Kidney Disease in the United States, Australia, and Thailand.
- Published in:
- American Journal of Public Health, 2008, v. 98, n. 7, p. 1306, doi. 10.2105/AJPH.2007.116020
- By:
- Publication type:
- Article
Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review and Meta-analysis.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 6, p. 603, doi. 10.1001/jama.2014.18574
- By:
- Publication type:
- Article
Industry-Sponsored Clinical Trials in Emerging Markets.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
- Published in:
- Annals of Internal Medicine, 2019, v. 171, n. 3, p. 181, doi. 10.7326/M19-0087
- By:
- Publication type:
- Article
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0213192
- By:
- Publication type:
- Article
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials.
- Published in:
- Diabetes Care, 2024, v. 47, n. 3, p. 501, doi. 10.2337/dc23-1450
- By:
- Publication type:
- Article
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).
- Published in:
- 2022
- By:
- Publication type:
- journal article
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium--Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2015, v. 38, n. 3, p. 403, doi. 10.2337/dc14-1237
- By:
- Publication type:
- Article
The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2014, v. 37, n. 1, p. 295, doi. 10.2337/dc13-1165
- By:
- Publication type:
- Article
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Linagliptin Lowers Albuminuria on Topof Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction.
- Published in:
- Diabetes Care, 2013, v. 36, n. 11, p. 3460, doi. 10.2337/dc13-0323
- By:
- Publication type:
- Article
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01619-0
- By:
- Publication type:
- Article
The impact of the COVID‐19 pandemic on medical education.
- Published in:
- Medical Journal of Australia, 2020, v. 213, n. 7, p. 334, doi. 10.5694/mja2.50762
- By:
- Publication type:
- Article
The impact of the COVID-19 pandemic on medical education.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reducing cardiovascular risk in people with diabetes and kidney disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Guideline for the diagnosis and management of hypertension in adults - 2016.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Is it time for Medi-change?
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy.
- Published in:
- American Journal of Nephrology, 2014, v. 40, n. 1, p. 64, doi. 10.1159/000364909
- By:
- Publication type:
- Article
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 4, p. 1103, doi. 10.1093/cvr/cvab128
- By:
- Publication type:
- Article
International trials in middle-income countries: different local scenarios require different ethical approaches.
- Published in:
- 2016
- By:
- Publication type:
- journal article
How many Australian deaths from heart disease and stroke could be avoided by a small reduction in population cholesterol levels?
- Published in:
- Nutrition & Dietetics, 2009, v. 66, n. 3, p. 158, doi. 10.1111/j.1747-0080.2009.01360.x
- By:
- Publication type:
- Article
The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system.
- Published in:
- Peritoneal Dialysis International, 2025, v. 45, n. 1, p. 52, doi. 10.1177/08968608231209850
- By:
- Publication type:
- Article
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3530, doi. 10.1111/dom.15685
- By:
- Publication type:
- Article
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3371, doi. 10.1111/dom.15678
- By:
- Publication type:
- Article